XML 73 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2013
Dec. 31, 2012
Assets    
Cash and due from banks $ 28,140 $ 26,471
Short-term investments 3,502 9,541
Investment in short-term receivables 246,817 81,044
Investment securities available for sale, at fair value 277,719 405,355
Investment securities held to maturity 94,904   
Mortgage loans held for sale 6,577 25,860
Loans, net of allowance for loan losses of $32,143 and $26,977, respectively 2,325,634 1,895,240
Bank premises and equipment, net 51,174 47,067
Accrued interest receivable 10,994 8,728
Goodwill and other intangible assets 8,433 8,682
Investment in real estate properties 10,147 6,935
Investment in tax credit entities 117,684 67,393
Cash surrender value of bank-owned life insurance 26,187 25,506
Other real estate 3,733 8,632
Deferred tax asset 51,191 16,589
Receivables from sales of investments   16,909
Other assets 23,781 20,915
Total assets 3,286,617 2,670,867
Deposits:    
Noninterest-bearing 291,080 239,538
Interest-bearing 2,439,727 2,028,990
Total deposits 2,730,807 2,268,528
Short-term borrowings 8,425 21,800
Repurchase agreements 75,957 36,287
Long-term borrowings 55,110 75,220
Accrued interest payable 6,682 5,557
Other liabilities 27,777 15,373
Total liabilities 2,904,758 2,422,765
Shareholders' equity:    
Common stock- par value $1 per share; 100,000,000 shares authorized; 18,514,271 shares issued and outstanding at December 31, 2013 and 13,052,583 shares issued and outstanding at December 31, 2012 18,514 13,052
Additional paid-in capital 237,063 128,984
Accumulated earnings 100,389 59,825
Accumulated other comprehensive loss, net (16,515) (2,926)
Total shareholders' equity 381,857 248,101
Noncontrolling interest 2 1
Total equity 381,859 248,102
Total liabilities and equity 3,286,617 2,670,867
Convertible Preferred Stock Series C [Member]
   
Shareholders' equity:    
Preferred stock 4,471 11,231
Series D Preferred Stock [Member]
   
Shareholders' equity:    
Preferred stock $ 37,935 $ 37,935